Pathophysiology and management of low high-density lipoprotein cholesterol

Area of Science:

• Cardiology
• Biochemistry

Background:

• Low high-density lipoprotein (HDL) cholesterol is a significant risk factor for coronary artery disease (CAD).
• Animal studies suggest that elevating HDL cholesterol levels can impede atherosclerosis progression.

Observation:

• Clinical trials provide some evidence that increasing HDL cholesterol may be beneficial.
• Further human data is required to confirm these benefits.

Findings:

• Increasing HDL cholesterol is a reasonable therapeutic consideration for patients with or at high risk for CAD.
• Ongoing clinical trials aim to identify optimal drug therapies for managing low HDL cholesterol.

Implications:

• This research highlights the importance of targeting HDL cholesterol in cardiovascular disease prevention.
• Future studies will guide clinical practice in managing dyslipidemia and reducing CAD events.